TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
MGX

Metagenomi, Inc.

Healthcare · Biotechnology

1.10$ -0.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MGX
Line item 2021 2022 2023 2024 2025
– +191.9% -12.0% -11.0% -31.9%
– +236.9% -24.2% -7.3% -35.8%
– +369.4% -23.8% -80.5% +52.3%
– +234.8% -25.1% -8.4% -35.2%
– +160.0% +92.4% -48.7% -75.7%
– +180.1% +2.4% -82.1% -30.3%
– +92.8% +41.9% -45.8% -38.5%
– +120.5% +126.2% +63.2% +7.7%
– +48.5% -10.9% -70.2% +179.4%
– – – – –
– – – – -32.5%
– – – – –
– +531.9% +0.0% -0.1% -0.4%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?